How a team of AIs discovered a promising lung-cancer drug

Stanford researchers developed Virtual Biotech, a system of 37,000 AI agents powered by Anthropic's Claude model, which analyzed over 55,000 clinical trials and identified a potential lung cancer drug target. While promising, the findings await experimental and clinical validation.